Physician Associate Studies (Taught Postgraduate) MSc

St Georges Physician Associate Studies (MPAS) is a postgraduate-level qualification for life science graduates who wish to become Physician Associates. Over the course of two years you will learn how to take medical histories, perform physical examinations, request and analyse investigations, diagnose illnesses and develop treatment and management plans. The course has an outstanding pass rate on the Physician Associate National Exam and excellent graduate employment.<br/><br/>St George’s shares its campus with one of the UKs largest teaching hospitals, making it the ideal place to study. With unrivalled access to clinical resources and working professionals, the course will fully equip you with all the skills and knowledge required to support a multidisciplinary team in the diagnosis and management of patients.<br/><br/>**Course Highlights**<br/><br/><br/>- The programme is the longest running physician associate course in the UK.<br/><br/><br/>- Dedicated primary care placement throughout Year 1. In Year 2, you will move through a wide range of specialities based in London’s top hospitals.<br/><br/><br/>- Year 1 student to staff ratio is approximately 9:1.<br/><br/><br/>**About St Georges, University of London**<br/><br/>Established in 1752, St George’s is the UK’s only university dedicated to medical and health sciences education, training and research. We share our site with a major London teaching hospital which is both on the clinical frontline for a diverse local community and a centre of excellence for specialist conditions. At St Georges, you’ll study in a clinical setting with like-minded individuals working across a variety of healthcare professions.<br/><br/>St George’s has enjoyed an outstanding track record of research and innovation in infectious disease ever since the ‘father of vaccinology’ and St Georges alumnus, Edward Jenner, created the world’s first vaccine (against smallpox). Recent research has included a focus on tuberculosis, malaria, HIV in low and middle-income countries and Covid-19.